IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
A Phase I Dose Finding Study of APO010 in Patients With Solid Tumors (AP1001)
This study has been completed.
Sponsor:
Onxeo
Information provided by (Responsible Party):
Onxeo
ClinicalTrials.gov Identifier:
NCT00437736
First received: February 20, 2007
Last updated: September 16, 2015
Last verified: September 2015
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | May 2009 |
| Primary Completion Date: | November 2008 (Final data collection date for primary outcome measure) |